Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
05/2007
05/09/2007EP1781653A1 3,4-disubstituted pyrazoles as cyclin dependent kinases (cdk) or aurora kinase or glycogen synthase 3 (gsk-3) inhibitors
05/09/2007EP1781652A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with tetrahydropyridine as crf antagonists
05/09/2007EP1781627A2 A method for preparing irbesartan and intermediates thereof
05/09/2007EP1781296A2 Quinazoline derivatives and their use in the treatment of thrombocythemia
05/09/2007EP1781290A2 Anti-inflammatory agents
05/09/2007EP1781170A1 Adduct of fluorescent dye and tumor avid tetrapyrrole
05/09/2007EP1408970B1 Indolines and tetrahydro-quinolines as prodrugs for tumour treatment
05/09/2007EP1323120A4 Fluoroscopic registration artifact with optical and/or magnetic markers
05/09/2007EP1254907B1 Pyrrolopyridazine compound
05/09/2007EP1238970B9 Cycloamine ccr5 receptor antagonists
05/09/2007EP1126855B1 Use of fused pyrrolocarbazoles for preventing/treating damage to sensory hair cells and cochlear neurons
05/09/2007CN1960993A 6,6-bicyclic substituted heterobicyclic protein kinase inhibitors
05/09/2007CN1960728A Conformationally constrained SMAC mimetics and the uses thereof
05/09/2007CN1958588A Synthesis of a kind of compound of new beta ¿C octamethylporphyrin, and application
05/09/2007CN1314686C Synthesis method of 2-amino-6-methyl-5-oxo-4-normal propyl-5-triazole [1,5-alpha] pyrimidine
05/08/2007US7214703 Compounds for modulators of chemokine activity
05/08/2007US7214692 Medical use for tachykinin antagonists
05/08/2007US7214688 Compounds
05/08/2007US7214686 adjust release of neurotransmitters; Parkinson's disease; tourette Syndrome; attention deficit disorders; schizophrenia
05/08/2007US7214685 Antibody directed enzyme prodrug therapy
05/08/2007US7214682 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo{1,2-a}pyrimidin-5(1h)one derivatives
05/08/2007US7214676 Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
05/08/2007US7214673 For therapy of psychosis and bipolar disorder
05/08/2007CA2373990C Pyrrolotriazine inhibitors of kinases
05/03/2007WO2007051062A2 Substituted dihydropyridines and methods of use
05/03/2007WO2007050721A2 Heterocyclic aspartyl protease inhibitors
05/03/2007WO2007050615A1 Novel compounds and their use related to compositions for treating glaucoma and/or ocular hypertension
05/03/2007WO2007050564A2 Boron-containing porphyrin compounds and their uses
05/03/2007WO2007050510A2 Hiv integrase inhibitors
05/03/2007WO2007050401A2 Tyrosine kinase inhibitors
05/03/2007WO2007050380A2 Tyrosine kinase inhibitors
05/03/2007WO2007050353A2 Tricyclic compounds useful as oxytocin receptor agonists
05/03/2007WO2007049820A1 Heterocyclic amide compound and use thereof
05/03/2007WO2007049736A1 Concentration crystallizer and method
05/03/2007WO2007048595A1 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses
05/03/2007WO2007032936A3 Azafused cyclin dependent kinase inhibitors
05/03/2007WO2007027734A3 Bicyclic and bridged nitrogen heterocycles
05/03/2007WO2007025880A3 Pyrazolone derivatives as 11-beta hsd1 inhibitors
05/03/2007WO2007023110A3 P38 map kinase inhibitors and methods for using the same
05/03/2007WO2007018998A3 Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulators
05/03/2007WO2007017468A3 Preparation of a 7h-pyrr0l0 [2 , 3-d] pyrimidine derivative
05/03/2007WO2006122011A3 Thiazole compounds and methods of use
05/03/2007US20070100142 Stereoselective Synthesis of Certain Trifluoromethyl-Substituted Alcohols
05/03/2007US20070100135 heating under microwave irradiation (3-hydroxymethylene-4-carboxylic acid ester-2-one)pyrroline derivatives in presence of inert solvent to produce 3,6-diphenylfuro[3,4-c]pyrrole-1,4-diones (furopyrroles); intermediates in process for preparation of diketopyrrolopyrroles; high yield and purity
05/03/2007US20070099944 ROCK-1 kinase and/or Aurora kinase inhibitors; indazolo-tetrahydropyrimidine-carboxamide derivatives; 4-(4-fluorophenyl)-N-1H-indazol-5-yl-6-methyl-2-oxo-1,2,3,4-tetrahydro-5-pyrimidinecarboxamide; antiinflammatory, antidiabetic, antiproliferative agents
05/03/2007US20070099942 AZA nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
05/03/2007US20070099940 Pth agonists
05/03/2007US20070099925 Novel imidazo based heterocycles
05/03/2007US20070099923 Therapeutic agents
05/03/2007US20070099914 Piperidine Derivatives
05/03/2007US20070099911 Pyrroloquinolinone derivatives as 5-hydroxytryptamine-6 ligands
05/03/2007US20070099910 Such as 1-[4-(4-amino-5-oxo-5H-pyrido[2,3-d]pyrimidin-8-yl)phenyl]-3-(2-fluoro-5-trifluoromethyl phenyl)urea; tyrosine kinase inhibitors, Raf kinase inhibitors; for treatment of tumors; pharmacokinetics; radiotherapy
05/03/2007US20070099904 Pharmaceutical composition for the treatment of cns and other disorders
05/03/2007US20070099899 Heterocyclic dihydropyrimidine compounds
05/03/2007US20070099897 Therapeutic compounds
05/03/2007US20070099874 Methods and compositions of novel triazine compounds
05/03/2007US20070095656 Method for purification of indole derivative trimer, electrode active substance comprising the purified trimer, method for manufacturing the electrode active substance, and electrochemical cell using the same
05/03/2007CA2627497A1 Heterocyclic amide compound and use thereof
05/03/2007CA2627234A1 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses
05/03/2007CA2626976A1 Heterocyclic aspartyl protease inhibitors
05/03/2007CA2626180A1 Tricyclic compounds useful as oxytocin receptor agonists
05/02/2007EP1780212A1 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVE
05/02/2007EP1779852A2 Methods for the production of sildenafil base and citrate salt
05/02/2007EP1778693A2 Tricyclic-heteroaryl compounds useful as kinase inhibitors
05/02/2007EP1778692A2 (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane
05/02/2007EP1778687A2 Fused ring heterocycle kinase modulators
05/02/2007EP1778677A1 Heterocyclic condensed compounds useful as antidiuretic agents
05/02/2007EP1778220A1 Constrained cyano compounds
05/02/2007EP1778082A1 Carboranylporphyrins and uses thereof
05/02/2007EP1701958B1 Pyrrolo-pyrazine derivatives useful as cb1-modulators
05/02/2007EP1549637B1 1- (indol-3-yl)carbonyl piperazine derivatives
05/02/2007EP1537181B1 Metaloxyphthalocyanine compounds
05/02/2007EP1470127B1 N, n'-dimethylated n-confused porphyrins
05/02/2007EP1414823B1 materials for selective trapping of carbon monoxide
05/02/2007EP1395606B1 Pyrrolidin-2-one derivatives as inhibitors of factor xa
05/02/2007EP0919556B1 Process for the preparation of hexanitrohexaazaisowurtzitanes
05/02/2007EP0869968B1 Growth-hormone secretagogues
05/02/2007CN1957059A Triazole derivatives and use thereof in organic light-emitting diode (OLED)
05/02/2007CN1957019A Deuterated polyimides and derivatives thereof
05/02/2007CN1956966A Quinazoline derivatives and therapeutic use thereof
05/02/2007CN1956943A Catalytic asymmetric desymmetrization of prochiral and meso cyclic anhydrides
05/02/2007CN1955178A New benzimidazole derivative
05/02/2007CN1955164A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
05/02/2007CN1313468C Purification of high-purity triethylenediamine (TEDA) by distillation
05/02/2007CN1313467C 6-(2,6-difluorophenyl)-triazolopyrimidines as fungecides
05/01/2007USRE39607 Herbicidal sulphonylamino(thio) carbonyl compounds
05/01/2007US7211677 3-amino-2-ethoxycarbonylpyrrole; chemical intermediate in synthesis of 3H,5H-pyrrolo[3,2-d]pyrimidin-4-one; a convergent synthesis route rather than a linear one
05/01/2007US7211669 therapy for depression; anxiolytic agents; eating disorders; post-traumatic stress disorders; headaches; drug addition; antiinflammatory agents
05/01/2007US7211666 N-Cyclopropyl-4-[[5-[(methoxyamino)carbonyl]-2-methylphenyl]amino]-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide; aminating with chloramine to produce a pyrrole with a Nitrogen nitrogen bond; reacting with formamide, cyclizing to form the pyrrolotriazine core; kinase inhibitors
05/01/2007US7211653 1,4-Dideoxy-1-C-(4-hydroxypyrrolo[3,2-d]pyrimidin-7-yl)-1,4-imino-D-ribitol derivatives or salts; parasite purine nucleoside, -hydrolase, -phosphorylase and/or phosphoribosyl transferase inhibitors; antiprotozoa, anticarcinogenic, antiinflammatory, and immunosuppressant agents; autoimmune diseases
05/01/2007US7211581 Substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives
05/01/2007US7211580 Compounds, compositions, and methods
05/01/2007US7211574 Central nervous system disorders; eating disorders; antidiabetic agents
05/01/2007US7211572 Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor
05/01/2007US7211545 Imidazo[1,2-a]pyrimidine and fungicidal compositions containing thereof
05/01/2007US7211241 Cascade polymer complexes that contain complexing ligands of general formula I A-(X (Y-(Z-(W KW)Z)y)x) (I), in which A stands for a nitrogen-containing cascade nucleus of base multiplicity a, X and Y, independently of one another, stand
05/01/2007US7211120 Method for forming a pattern of an organic semiconductor film
04/2007
04/26/2007WO2007047925A2 Swallowtail motifs for imparting water solubility to porphyrinic compounds
04/26/2007WO2007046747A1 Novel bicyclic sulfonamides for use as glucocorticoid receptor modulators in the treatment of inflammatory diseases
04/26/2007WO2007046575A1 The application using non-covalent bond between a cucurbituril derivative and a ligand